Research press release


Nature Medicine

New treatment for inborn error of metabolism


エチルマロン脳症の原因は、硫化物の代謝に重要な働きをするあるミトコンドリアタンパク質の遺伝子に起こった変異である。硫化物はおもに腸内微生物叢によって作られるので、M Zevianiたちは、抗生物質(メトロニダゾール)とNアセチルシステイン(硫化物を緩衝する分子の前駆体)とを一緒にマウスとヒト患者に投与して、効果を検証した。


Combined treatment with two drugs, metronidazole and N-acetylcysteine, is effective in treating children with ethylmalonic encephalopathy ― a birth defect of the metabolism that affects the gastrointestinal, circulatory, and nervous systems. The article in this week's Nature Medicine suggests that this therapy may be useful in the treatment of children suffering from the genetic disorder.

Ethylmalonic encephalopathy is caused by mutations in a mitochondrial protein important for metabolizing sulfide. As sulfide is largely a product of intestinal microbes, Massimo Zeviani and colleagues tested the effect of an antibiotic ― metronidazole ― together with N-acetylcysteine ― a precursor of the sulfide-buffering molecule ― in mice and in patients with this disease.

The treatment substantially prolonged the lifespan of mice carrying disease-causing mutations and resulted in marked clinical improvement in five affected children, with no adverse effects. A larger clinical trial will now be necessary to confirm these encouraging results.

doi: 10.1038/nm.2188


メールマガジンリストの「Nature 関連誌今週のハイライト」にチェックをいれていただきますと、毎週各ジャーナルからの最新の「注目のハイライト」をまとめて皆様にお届けいたします。